Pfizer partners with Clear Creek Bio to develop oral COVID-19 drug




  • In Health
  • 2022-12-06 13:45:52Z
  • By Reuters
 

(Reuters) - Pfizer Inc and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.

Charlotte Allerton, Pfizer's chief scientific officer, said COVID-19 has "the potential to remain a global health concern for years to come".

Pfizer already has a COVID antiviral pill Paxlovid, which the drugmaker expects to generate about $22 billion in revenue this year.

Pfizer has been making various deals to boost its portfolio. This year, it has announced acquisitions of Biohaven Pharmaceutical Holding Co and Global Blood Therapeutics for $11.6 billion and $5.4 billion, respectively, and also launched a company with Roivant Sciences focused on an experimental bowel disease treatment.Under the agreement with Clear Creek Bio, the pharmaceutical giant will pay an undisclosed amount upfront as well as make additional milestone payments along with royalties on future product sales.

(Reporting by Khushi Mandowara in Bengaluru; Editing by Krishna Chandra Eluri)

COMMENTS

More Related News

Drug companies face COVID cliff in 2023 as sales set to plummet
Drug companies face COVID cliff in 2023 as sales set to plummet
  • US
  • 2023-02-06 11:05:39Z

Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff...

'We still don't know it's over': will Covid surge after US ends emergency?

Experts remain concerned about virus as Biden administration says it will let the public health emergency expire in May

Job Market 2023: How
Job Market 2023: How 'Long COVID' May Impact Hiring This Year

Many Americans have been infected with COVID-19, and now many are living with symptoms indefinitely. According to the Centers for Disease Control and...

Foxconn
Foxconn's January sales surge as China COVID disruption shaken off
  • US
  • 2023-02-05 07:52:25Z

TAIPEI (Reuters) -Taiwan's Foxconn, the world's largest contract electronics maker and major iPhone assembler for Apple Inc, said on Sunday its revenue in...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health